News

The future of nanomedicines – nanosimilars

Published on 2013/11/12

First there were generics, then came biosimilars and soon the European Medicines Agency (EMA) is anticipating the first nanosimilars, or similar versions of originator nanomedicines. Nanomedicine is ...

17 views

Read more →

California governor vetoes biosimilars bill

Published on 2013/11/08

On 12 October 2013, California Governor Jerry Brown vetoed legislation known as SB 598, a bill that some believed would have impeded access to biosimilars. The Generic Pharmaceutical Association (GPh...

3 views

Read more →

Regulation of similar biotherapeutic products in Latin America

Published on 2013/11/06

Regulation of similar biotherapeutic products (SBP) in Latin America varies widely among different countries and, although many countries have yet to introduce guidance for biosimilars, the region is ...

14 views

Read more →

Generics may be allowed to change drug labelling

Published on 2013/11/04

FDA has proposed a new rule which would allow generics makers to change their labelling in the same way as brand-name manufacturers. Under current regulations generics manufacturers cannot update t...

3 views

Read more →

Use of brand-name drugs increasing healthcare costs in US

Published on 2013/11/01

Patients with diabetes who are covered by the US healthcare insurance Medicare are two to three times more likely to use expensive brand-name drugs compared to patients treated within the Veterans Aff...

5 views

Read more →

Biosimilar competition in Europe

Published on 2013/10/30

A study of five European Union (EU) countries has revealed that Germany provides the most favourable environment for uptake of biosimilars. The study, which was led by Professor Henry Grabowski, Di...

51 views

Read more →

Patient care threatened by cancer drug shortages

Published on 2013/10/28

Drug shortages are affecting most US oncologists, impacting on life-saving patient care, according to the findings of the largest study yet to quantify the impact of cancer drug shortages. Of 250 boar...

9 views

Read more →

Generics combo non-inferior to treatment with Enbrel

Published on 2013/10/25

A study carried out by researchers from the US Department of Veterans Affairs and the Canadian Institutes for Health Research has found that a combination of three generic drugs is non-inferior to tre...

13 views

Read more →

EMA approves first monoclonal antibody biosimilars

Published on 2013/10/23

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) announced on 28 June 2013 that it had recommended granting of marketing authorizations for the first t...

10 views

Read more →

Ranbaxy faces lawsuit in India

Published on 2013/10/21

An Indian lawyer has filed a lawsuit asking the Indian Supreme Court to investigate Ranbaxy Laboratories (Ranbaxy), its executives and Indian drug control officers, as well as to shut down two of Ranb...

12 views

Read more →

Erythropoietin biosimilars in bone marrow transplantation and stem cell donation

Published on 2013/10/18

Combination therapy with granulocyte colony-stimulating factor (G-CSF) and erythropoietin (EPO) has been used with the aim of accelerating the recovery of red blood cells following autologous bone mar...

3 views

Read more →

Infliximab biosimilar comparable to Remicade

Published on 2013/10/16

South Korean biotechnology company Celltrion presented results of its extended trials for its biosimilar infliximab candidate Remsima (CT-P13) at the European League Against Rheumatism (EULAR) 2013 Co...

8 views

Read more →